GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zhejiang Sunflower Great Health Co 300111.SZ · CNY

Information Technology · Shenzhen · 🇨🇳 China

Compare

3.47

+5.47%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥271.5m

FY2016FY2025

Net income

−CN¥4.4m

FY2016FY2025

Free cash flow

−CN¥5.6m

FY2016FY2025

Shareholders' equity

CN¥682.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥271.5mCN¥330.4mCN¥338.4mCN¥335.9mCN¥297.3mCN¥287.0mCN¥836.6mCN¥900.2mCN¥1.53bnCN¥1.60bn
Gross profitCN¥56.8mCN¥74.2mCN¥83.6mCN¥96.2mCN¥108.9mCN¥102.3mCN¥141.5mCN¥7.9mCN¥179.0mCN¥335.1m
Research and developmentCN¥10.8mCN¥22.0mCN¥19.1mCN¥14.2mCN¥12.3mCN¥11.3mCN¥26.0mCN¥20.8mCN¥41.3mCN¥58.2m
Operating income−CN¥6.0mCN¥12.4mCN¥26.0mCN¥5.9mCN¥54.5mCN¥73.8m−CN¥65.6m−CN¥720.1mCN¥53.2mCN¥83.0m
Net income−CN¥4.4mCN¥7.8mCN¥21.7m−CN¥1.1mCN¥53.4mCN¥55.9m−CN¥114.9m−CN¥1.12bnCN¥23.7mCN¥30.6m
Diluted earnings per share-0.000.010.02-0.000.050.05-0.09-1.000.020.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥984.2mCN¥999.1mCN¥1.24bnCN¥616.2mCN¥631.6mCN¥564.4mCN¥694.0mCN¥1.46bnCN¥2.70bnCN¥2.80bn
Cash and short-term investments—CN¥567.4mCN¥879.1mCN¥233.2mCN¥206.1mCN¥225.6mCN¥146.7mCN¥182.2mCN¥167.6mCN¥218.5m
Total liabilitiesCN¥165.0mCN¥176.1mCN¥432.5mCN¥201.4mCN¥221.4mCN¥293.4mCN¥522.3mCN¥1.28bnCN¥1.38bnCN¥1.50bn
Debt—CN¥4.9mCN¥46.6mCN¥33.1mCN¥932,925CN¥2.0mCN¥113.7mCN¥518.1mCN¥739.6mCN¥676.9m
Shareholders' equityCN¥682.0mCN¥686.2mCN¥678.3mCN¥285.8mCN¥286.9mCN¥150.2mCN¥50.3mCN¥197.6mCN¥1.31bnCN¥1.30bn
Shares outstanding1,597m1,040m1,338m1,189m1,033m1,105m1,235m1,120m1,389m347m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥4.2mCN¥31.4mCN¥2.9mCN¥24.2mCN¥99.3mCN¥53.3mCN¥58.5mCN¥64.6mCN¥205.5mCN¥365.1m
Capital spending−CN¥9.8m−CN¥12.9m−CN¥10.3m−CN¥42.1m−CN¥16.9m−CN¥22.4m−CN¥20.7m−CN¥5.1m−CN¥39.3m−CN¥44.2m
Free cash flow−CN¥5.6mCN¥18.5m−CN¥7.4m−CN¥18.0mCN¥82.4mCN¥31.0mCN¥37.8mCN¥59.5mCN¥166.2mCN¥321.0m
Dividends paid−CN¥8,306−CN¥1.1m−CN¥1.7m−CN¥186,998−CN¥60,340−CN¥17.6m−CN¥20.0m−CN¥31.4m−CN¥40.8m−CN¥63.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥54.0mCN¥54.6mCN¥72.0mCN¥55.1mCN¥72.2mCN¥72.2mCN¥103.4mCN¥69.4m
Gross profitCN¥10.8mCN¥13.2mCN¥15.7mCN¥13.4mCN¥14.7mCN¥13.0mCN¥20.0mCN¥17.8m
Operating income−CN¥2.4m−CN¥906,604−CN¥730,755CN¥46,851CN¥2.8m−CN¥440,073CN¥7.4mCN¥3.0m
Net income−CN¥7.2m−CN¥5.2m−CN¥5.7mCN¥145,516CN¥1.3m−CN¥130,949CN¥5.0mCN¥980,684
Diluted earnings per share-0.00-0.00-0.000.000.00-0.000.000.00
Cash from operations———CN¥2.0m−CN¥19.0mCN¥28.0m−CN¥21.0mCN¥40.0m
Capital spending−CN¥1.0m−CN¥2.0m—−CN¥4.0m—−CN¥5.0m—−CN¥4.0m
Free cash flow———−CN¥2.0m—CN¥23.0m—CN¥36.0m
Total assetsCN¥983.1mCN¥968.3mCN¥984.2mCN¥969.2mCN¥981.8mCN¥987.9mCN¥999.1mCN¥1.02bn
Cash and short-term investments———CN¥519.2mCN¥565.6mCN¥583.3mCN¥567.4mCN¥636.9m
Debt———CN¥73.4mCN¥87.3mCN¥89.7mCN¥4.9mCN¥9.0m
Shareholders' equityCN¥669.8mCN¥676.9mCN¥682.0mCN¥687.6mCN¥687.4mCN¥686.1mCN¥686.2mCN¥681.3m

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin20.9%22.5%24.7%28.6%36.6%35.7%—
Operating margin-2.0%4.4%8.9%1.6%23.4%25.8%—
Net margin-1.6%2.4%6.4%-0.3%18.0%19.5%—
Return on equity-0.6%1.1%3.2%-0.4%18.6%37.2%—
Return on assets-0.4%0.8%1.8%-0.2%8.5%9.9%—
Free cash flow yield0.3%1.3%0.3%1.7%3.5%2.1%—
Revenue growth-17.8%-2.4%0.8%13.0%3.6%-65.7%—
Earnings growth-156.0%-64.0%-2009.9%-102.1%-4.4%-148.6%—
Current ratio6.23x5.79x2.75x2.81x3.22x2.03x—
Debt to equity—0.01x0.07x0.11x0.15x0.01x2.26x
Equity ratio69.3%68.7%54.6%46.4%45.4%26.6%—
Interest coverage-585.52x7.38x5.67x6.21x249.41x25.12x—
R&D as a share of sales4.0%6.7%5.6%4.2%4.1%4.0%—
Buybacks as a share of market value-53.5%22.3%-12.6%-15.1%6.5%10.5%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-6.8%-1.1%-17.3%
Net income56.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin21.8%24.4%28.1%18.4%
Operating margin1.1%3.0%9.0%-4.5%
Net margin0.6%1.9%7.2%-11.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-2232.9430.7187.1-3404.260.963.3-25.1-2.0210.459.7
Price to sales36.110.212.011.510.912.33.52.53.31.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 3 Jun 2011.

FY2011
Paid in the year0.182
  • 11-for-5 split · 4 Sept 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.